Introduction
Acute kidney injury (AKI) has replaced the term acute renal failure and new definitions have been proposed to allow earlier detection. Clinically, AKI is characterized by a sudden deterioration of normal kidney function. This dysfunction causes abnormal regulation of fluid, electrolytes, blood pressure, and removal of waste products. In addition, growing evidence shows that the kidneys play a key role in the development and regulation of the inflammatory process that occurs in multiorgan failure [1,2 ,3,4] . Over the past several years, tremendous effort and a large number of resources have been placed to improve our ability to diagnose AKI early in the disease state. It is hoped that these new biomarkers will be able to diagnose AKI earlier in the disease and differentiate different causes and stages of AKI. Until these biomarkers are adopted, functional markers, such as serum creatinine (SCr) and cystatin C, are used to diagnose AKI. This review will highlight recent studies that have improved our ability to diagnose AKI, review the differential diagnosis of AKI, highlight the importance of cumulative fluid status in the assessment of the critically ill child with AKI, and finally suggest some key management questions/ strategies important to the care of the pediatric patient with AKI. Does this critically ill child have acute kidney injury?
staging system, which will harmonize these recent definitions. It is expected that this definition will be accepted globally in 2011 (see Table 1 for comparison of RIFLE, pediatric RIFLE (pRIFLE), and AKIN). The adjustments in these definitions over time should be considered gradual evidence-based improvements. These SCr-based classifications/definitions of AKI have provided great insights; however, when using these definitions, it is important to acknowledge the shortcoming and limitations of using SCr-based AKI definitions.
The use of changes in function markers such as SCr to define AKI is not ideal, as SCr concentrations may not change until 25-50% of the kidney function has already been lost, and thus it may take days after an injury before a significant rise in SCr is seen [13] . At lower GFR, SCr will overestimate renal function owing to tubular secretion of creatinine [13] . SCr varies by muscle mass, hydration status, sex, age and gender, and method of measurement [14, 15] . Once a patient receives dialysis, SCr can no longer be used to assess kidney function, as SCr is easily dialyzed. In neonates, SCr in the first few days of life reflects mother's SCr; thereafter, the SCr improves at different rates depending on the degree of gestational age [16] . In addition, SCr-based definitions fail to delineate the severity, timing, and cause of the injury.
Despite the above concerns about these AKI definitions, these new SCr-based classifications/definitions of AKI have allowed valuable comparisons among different studies, which have shed new light on the epidemiology of AKI. Using these definitions, we have learned that AKI is an independent predictor of mortality in critically ill neonates [17] , children [6, 11 ] , and adults [18] [19] [20] [21] [22] , even after controlling for comorbidities, interventions, and demographics. Even small changes in SCr, which previously were ignored, are associated with poor outcomes [9 ,23] .
Hopefully, as research on novel AKI biomarkers and therapies continues, these definitions can be adapted such that patient risk can be stratified, pathophysiologic cause can be determined and clear time points for interventions can be deduced.
What is the cause of AKI in this critically ill child?
With advancements in the field of critical care medicine and other fields of pediatrics, the cause of AKI has changed in large tertiary centers, whereby fewer than 10% of those with AKI [24] and those who receive continuous renal support [25] have a primary renal diagnosis. The approach to uncovering the cause of AKI has not changed much over the last decade, although future biomarker and radiologic studies may help delineate the cause of AKI. Until then, the following should be assessed in critically ill children with AKI:
(1) Risk factors for AKI (chronic kidney disease, cardiac disease, liver failure, and nephrotoxic medications).
(2) Assessment for potential causes of AKI (decreased intake, increased losses, urinary tract symptoms, drug exposure, presence of sepsis, fever, rashes, and joint pains). (3) Clinical examination findings of rash, uveitis, joint swelling, fever, skin perfusion, heart rate, blood pressure, audible renal bruits, and a palpable bladder. (4) Laboratory/radiologic tests will depend on the history and physical examination. They include: serum electrolyte, blood urea, SCr, cystatin C, urinalysis, microbiology, urinary electrolytes, chest radiograph, ECG, renal ultrasound (to evaluate for congenital abnormalities and obstruction), and kidney biopsy.
AKI is commonly multifactorial. Classically, the underlying cause of rising SCr/drop in urine output has been divided into prerenal azotemia, renal injury, and postrenal obstruction.
Prerenal azotemia
Prerenal azotemia (sometimes referred to 'prerenal failure', but perhaps better termed 'acute renal success') occurs in response to decreased renal blood flow (RBF). Causes of prerenal azotemia are listed in Table 2 . When low RBF occurs, renal autoregulation preserves GFR by increasing renal sympathetic tone, activation of the renin-angiotensin-aldosterone system, and increased activation of hormones such as vasopressin and endothelin, which enhance proximal tubular sodium and water reabsorption in those with intact tubular function. These renal hemodynamic changes lead to decreased water and sodium losses, so as to maintain systemic volume expansion and blood pressure.
In those with decreased RBF and intact tubular function, increased sodium and urinary urea reabsorption occurs. This is reflected by the low urine sodium concentrations (FE Na < 1%), low urine urea concentration 202 Nephrology
Key points
New categorical serum creatinine-based definitions of pediatric acute kidney injury have been devised. Evaluation of the pediatric patient with acute kidney injury should focus on determining the underlying cause and evaluation for renal support therapy. Cumulative fluid overload is strongly associated with poor clinical outcomes in critically ill children; therefore, monitoring this important 'vital sign' is essential to determine optimal time for renal support therapy.
(FE urea < 35%) and increased blood urea : creatinine ratios. These renal indices should be interpreted with caution in patients on diuretics, those with salt-losing state, and those with chronic kidney disease. In a recent study of children with AKI, FE urea was found to be a more useful index [26 ] .
This period of renal hypoperfusion, which has been recently referred to as 'renal angina' is critical to recognize and treat to prevent cellular damage to occur [27 ] . Correction of the underlying cause of hypoperfusion restores GFR unless renal hypoperfusion is severe enough to cause renal tubular and endothelial damage. Once parenchymal damage occurs, renal tubular cell damage occurs even if renal perfusion is restored.
Intrinsic acute kidney injury
Although disease process can affect more than one part of the kidney, intrinsic kidney injury can be divided into tubular, intrinsic, vascular, and glomerular.
Ischemic acute kidney injury
Prerenal azotemia and ischemic AKI are a continuum of physiologic responses. Prolonged or severe hypoperfusion causes injury to renal parenchymal cells, particularly to tubular epithelium of the terminal medullary portion of the proximal tubule (S3 segment) and of the medullary portion of the thick ascending limb of the loop of Henle. In contrast to prerenal azotemia, renal function abnormalities in intrinsic AKI are not immediately reversible. The severity of intrinsic AKI ranges from mild tubular dysfunction, to acute tubular necrosis, to renal infarction and corticomedullary necrosis with irreversible renal damage.
The course of ischemic AKI may be subdivided into the prerenal, initiation, extension, maintenance, and recovery phases [28] . If restoration of RBF occurs during the prerenal azotemia stage, GFR can return promptly to normal. The initiation phase includes the original insult and the associated events resulting in a drop in GFR. Tubular dysfunction with low GFR represents the maintenance phase. The duration of the maintenance phase depends on the severity and duration of the initial insult. The recovery phase is characterized by the gradual restoration of GFR and tubular functions, which can take months to occur. Recognition of the different phases of intrinsic AKI is helpful in the diagnosis, clinical management, and prognostication of the disorder.
Not only are tubular epithelial cells critical in the pathophysiology of ischemic AKI, but damage to the innermost lining of the renal vascular system, endothelial cells, has a critical role in the initiation, extension, maintenance, and recovery phases of ischemic AKI [29] [30] [31] . Damaged endothelial and tubular cells not only lead to dysfunction within the kidney but also produce a systemic inflam-Acute kidney injury in critically ill children Askenazi 203 matory response that leads to distant organ dysfunction in brain, lung, heart, liver, bone marrow, and gastrointestinal tract [32] [33] [34] .
Nephrotoxic acute kidney injury
Pharmacologic agents are one of the most common causes of nephrotoxic AKI, although endogenous substances like hemoglobin, myoglobin, and uric acid can also be harmful. These toxins can cause AKI by decreasing renal perfusion (NSAIDs, diuretics, and ACE-inhibitors), direct tubular injury (aminoglycosides, cephalosporins, amphotericin B, rifampin, vancomycin, NSAIDs, contrast media and myoglobin/hemoglobin), interstitial nephritis, or tubular obstruction (acyclovir and uric acid). A recent study by Zappitelli et al. [10 ] shows that children treated with aminoglycosides for at least 5 days had a 33% incidence of AKI (by AKIN criteria), longer length of stay, and substantial/added hospital expenditures.
Acute obstruction
The most common cause of obstructive induced kidney dysfunction in pediatrics is secondary congenital malformations including imperforate prepuce, urethral stricture, prune belly syndrome, and posterior urethral valves. Other causes of acute obstruction include neurogenic bladder, extrinsic compression, and intrinsic obstruction from renal calculi or fungal balls. Depending on the cause and associated damage to the kidneys, relief of the obstruction is imperative to restore renal function.
Primary renal causes of acute kidney injury: glomerular/ vascular cause or acute kidney injury
In large tertiary centers, multiorgan failure and nephrotoxic medications make up a large portion of AKI cases, whereas primary renal conditions make up a small pro-portion of pediatric AKI. Nonetheless, the ability to diagnose these conditions is very important, as the overall management of the patients will differ considerably and may include specific therapies such as plasma exchange and immunosuppressive therapies.
Glomerulonephritis/vascular diseases should be suspected when a child presents with AKI without an identifiable cause. Clinical signs and symptoms dictate the work-up in these patients. Those with pulmonary hemorrhage should be evaluated for glomerular/vascular cause. Examination of the urine sediment for red blood cell casts can differentiate glomerular/vascular from tubular injury. Laboratory evaluation for autoimmune antibodies [such as pantineutrophil cytoplasmic antibodies (p-ANCAs) and c-ANCAs, antiglomerular basement membrane antibody, and antinuclear antibodies], complement fragments (C3, C4, and CH50) and a diagnostic kidney biopsy may be helpful to unmask the cause and stage of the disease, and determine the extent of active (treatable) disease.
Children with microangiopathies may present with AKI, thrombocytopenia, hemolytic anemia, elevated lactate dehydrogenase and low haptoglobin. These microangiopathies arise from underlying damage to the endothelial cells. In the case of diarrhea-associated hemolytic uremic syndrome (HUS), this endothelial damage comes from bacterial endotoxin such as the toxin expressed by Escherichia coli 0157. Secondary causes of atypical HUS/thrombocytopenia purpura include disorders of complement regulation (factor H deficiency, factor I deficiency, C3nephritic factor, and membrane cofactor protein), inherited or acquired ADAM metalloproteinase with thrombospondin type 1 motif, 13 (ADAMTS-13) deficiency, defects in cobalamin metabolism, and secondary to 204 Nephrology medications. Streptococcus pneumonia-associated HUS and thrombocytopenia-associated multiorgan failure are unique entities that require special consideration. Excellent reviews of the evaluation and management of these conditions have recently been published [25,35 ,36 ,37] .
Assessment for cumulative fluid overload: the forgotten vital sign
When evaluating a critically ill child with AKI, one must determine whether renal support therapy is indicated. The phrase 'renal support' may be better than 'renal replacement' as partial dysfunction may be an indication for technologic interventions. This is analogous to the use of 'cardiac/ventilator support' as opposed to 'cardiac/ ventilator replacement'. Studies in pediatrics show that prevention and treatment of fluid overload are two of the most common reasons for initiation of renal support therapy [25] . Fluid overload can be calculated as follows:
½ðfluid input in litersÞ À ðfluid output in litersÞ=
ICU admission weight in kilograms
When Goldstein et al. [38] first published on the potential detrimental effects of cumulative fluid overload, there was a lot of resistance from the critical care community about their conclusions, as there were new data on the importance of aggressive goal-directed use of fluids in the early course of sepsis [39] [40] [41] .
Since the initial description of the potential detrimental effects of fluid overload, pediatric [38,42,43,44 ,45,46] and adult studies [47, 48] consistently show that children and adults who accumulate a higher cumulative percentage fluid overload have worse outcomes even after controlling for severity of illness. For example, using the prospective pediatric continuous renal replacement therapy (ppCRRT) registry, Sutherland et al. [44 ] showed that those who initiated renal replacement therapy with cumulative percentage fluid overload less than 20% had better survival than those who had cumulative fluid excess higher than 20% (46 vs. 68%, P < 0.01). After controlling for potential confounders, the adjusted mortality odds of death was an alarming 8.5 [95% confidence interval (CI) 2.8-25.7, P < 0.01]. A similar study of a large adult database [48] shows the same effect not only for those who received renal support therapy but also in those who did not receive renal support. This effect may be even greater in critically ill bone marrow transplant recipients [49,50,51 ,52] .
Management of acute kidney injury in critically ill patients
Although the definition of AKI may change over time as newer biomarkers are tested, if renal injury is indeed confirmed, several strategies should be implemented.
These interventions can help determine the underlying cause and eliminate further damage to the injured kidney, and the response to therapies may help uncover the underlying cause.
(1) Diagnostic evaluation to uncover the underlying cause. This value should be recorded at least daily to provide a sense of how the patient is handling fluids over the course of the hospitalization. This important vital sign is very informative to the critical care team when balancing the potential benefits and risk of renal support therapy. (7) If the patient has >10% cumulative fluid overload, evaluation for renal support therapy should occur. If a patient develops >20% cumulative fluid overload, initiation of renal support therapy should be strongly considered. (8) If continuous renal support is prescribed, supply an extra 1 g/kg per day of protein to make up for losses typical of continuous renal support therapies. (9) On the basis of recent dialysis dose recommendations for critically ill patients, a minimum of 20 ml/kg per day of effluent clearance should be provided to children who need continuous renal support. If intermittent hemodialysis is chosen as a way to support the dysfunctional kidney, a minimum of three times a week therapy with at least a KT/V (a number used to quantify hemodialysis where K ¼ dialyzer clearance, t ¼ time, and v is the volume of distribution) of 1.2 should be achieved [53 ,54 ] .
Conclusion
Categorical definitions of AKI have been created to detect AKI early in the disease process. Until interventions to treat AKI are found, clinical evaluation, strategies to prevent and/or treat fluid overload, avoiding nephrotoxic medications, and adequate renal support are key to maximize outcomes in critically ill children with AKI.
